CoChat

XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors

Open access

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Dendritic cells (DCs) are major regulators of innate and adaptive immune responses. DCs can be classified into plasmacytoid DCs and conventional DCs (cDCs) type 1 and 2. Murine and human cDC1 share the mRNA expression of XCR1. Murine studies indicated a specific role of the XCR1–XCL1 axis in the induction of immune responses. Here, we describe that human cDC1 can be distinguished into XCR1 − and XCR1 + cDC1 in lymphoid as well as nonlymphoid tissues. Steady-state XCR1 + cDC1 display a preactivated phenotype compared to XCR1 − cDC1. Upon stimulation, XCR1 + cDC1, but not XCR1 − cDC1, secreted high levels of inflammatory cytokines as well as chemokines. This was associated with enhanced activation of NK cells mediated by XCR1 + cDC1. Moreover, XCR1 + cDC1 excelled in inhibiting replication of Influenza A virus. Further, under DC differentiation conditions, XCR1 − cDC1 developed into XCR1 + cDC1. After acquisition of XCR1 expression, XCR1 − cDC1 secreted comparable level of inflammatory cytokines. Thus, XCR1 is a marker of terminally differentiated cDC1 that licenses the antiviral effector functions of human cDC1, while XCR1 − cDC1 seem to represent a late immediate precursor of cDC1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2300343120

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. The cDC1 compartment comprises XCR1− and XCR1+ cells. (A) Single-cell suspensions of human blood were stained with a panel of fluorochrome-coupled antibodies (SI Appendix, Table S5). Samples were acquired using a BD LSRFortessa and analyzed using FlowJo software. After gating for living cells as shown in SI Appendix, Fig. S2, T cells, B cells, NK cells, and monocytes were excluded. The remaining HLA-DR+ cells were clustered using the algorithm UMAP. Scatter plots show UMAP with gated cDC1 (yellow-orange), cDC2 (red), pDC (blue) and Axl+ DC (green). Color-coded heat maps depict the expression of select markers for the identification of the different DC subpopulations. (B and C) Gated (B and C) blood, (C) lymphoid tissue and lung cDC1 as shown in SI Appendix, Fig. S2 were stained with PE-coupled anti-XCR1 (clone: S15046E, BioLegend) or appropriate isotype control (rat IgG2a). Cells were segregated into XCR1+ and XCR1− cells based on the signal in the isotype control. (B) Histograms show one representative blood donor. (C) Scatter plot (horizontal line: mean + SD) shows the ratio of XCR1+ and XCR1− cDC1 in blood, spleen, thymus, tonsil, and lung donors (n = 3 to 11).
Fig. 1. The cDC1 compartment comprises XCR1− and XCR1+ cells. (A) Single-cell suspensions of human blood were stained with a panel of fluorochrome-coupled antibodies (SI Appendix, Table S5). Samples were acquired using a BD LSRFortessa and analyzed using FlowJo software. After gating for living cells as shown in SI Appendix, Fig. S2, T cells, B cells, NK cells, and monocytes were excluded. The remaining HLA-DR+ cells were clustered using the algorithm UMAP. Scatter plots show UMAP with gated cDC1 (yellow-orange), cDC2 (red), pDC (blue) and Axl+ DC (green). Color-coded heat maps depict the expression of select markers for the identification of the different DC subpopulations. (B and C) Gated (B and C) blood, (C) lymphoid tissue and lung cDC1 as shown in SI Appendix, Fig. S2 were stained with PE-coupled anti-XCR1 (clone: S15046E, BioLegend) or appropriate isotype control (rat IgG2a). Cells were segregated into XCR1+ and XCR1− cells based on the signal in the isotype control. (B) Histograms show one representative blood donor. (C) Scatter plot (horizontal line: mean + SD) shows the ratio of XCR1+ and XCR1− cDC1 in blood, spleen, thymus, tonsil, and lung donors (n = 3 to 11).CC BY-NC-ND · PubMed Central
Fig. 2. Transcriptional differences of XCR1− and XCR1+ cDC1. XCR1− and XCR1+ cDC1 were sorted as shown in SI Appendix, Fig. S4. Subsequently, cells were stimulated or not with 5 µg/mL R848 for 3 h. mRNA expression of 800 genes was determined using NanoString technology (770 genes from the nCounter Human Myeloid Innate Immunity V2 Panel and 30 DC- and inflammation-specific genes) as described before (44). (A) Eight samples (two donors, two subpopulations, two conditions) of 800 gene features were clustered using principal components analysis (PCA). Samples of XCR1− cDC1 are shown as black (steady state) and dark gray (R848) circles, while samples of XCR1+ cDC1 are depicted as white (steady state) and light-gray (R848) circles. (B) Heatmap shows DEGs between XCR1− and XCR1+ cDC1 in the steady state (cultured in medium for 3 h) or after stimulation with R848. (C) Gene expression values in (B) were analyzed by Gene Set Enrichment Analysis. Shown Pathways were significantly enriched in XCR1+ cDC1 compared to XCR1− cDC1 in the steady state (cutoff: a normalized enrichment score lower than −1.5 and P-value lower than 0.05).
Fig. 2. Transcriptional differences of XCR1− and XCR1+ cDC1. XCR1− and XCR1+ cDC1 were sorted as shown in SI Appendix, Fig. S4. Subsequently, cells were stimulated or not with 5 µg/mL R848 for 3 h. mRNA expression of 800 genes was determined using NanoString technology (770 genes from the nCounter Human Myeloid Innate Immunity V2 Panel and 30 DC- and inflammation-specific genes) as described before (44). (A) Eight samples (two donors, two subpopulations, two conditions) of 800 gene features were clustered using principal components analysis (PCA). Samples of XCR1− cDC1 are shown as black (steady state) and dark gray (R848) circles, while samples of XCR1+ cDC1 are depicted as white (steady state) and light-gray (R848) circles. (B) Heatmap shows DEGs between XCR1− and XCR1+ cDC1 in the steady state (cultured in medium for 3 h) or after stimulation with R848. (C) Gene expression values in (B) were analyzed by Gene Set Enrichment Analysis. Shown Pathways were significantly enriched in XCR1+ cDC1 compared to XCR1− cDC1 in the steady state (cutoff: a normalized enrichment score lower than −1.5 and P-value lower than 0.05).CC BY-NC-ND · PubMed Central
Fig. 3. XCR1+ cDC1 are superior in the secretion of inflammatory cytokines. XCR1− and XCR1+ cDC1 were sorted as shown in SI Appendix, Fig. S4. Subsequently, cells were stimulated or not either with 5 µg/mL R848 or 5 µg/mL pIC for 12 h. Supernatants of the cells were harvested and analyzed for the secretion of IL-12/IL-23p40, IL-12p70, IL-6, TNF, IFNλ1, IFNλ2/3, IFNα2, IFNβ, CXCL10, CCL3, CCL4, and CCL5 using the LEGENDplex Human Anti-Virus Response Panel (BioLegend). Samples were acquired using a BD LSRFortessa and data were analyzed using the LEGENDplex software suit (BioLegend). Scatter plots (black, filled circles: XCR1−; open circles: XCR1+) depict individual donors. Data for XCR1− and XCR1+ cDC1 from the same donor are connected by line. *P < 0.05; **P < 0.01 (N = 6, paired Student’s t test).
Fig. 3. XCR1+ cDC1 are superior in the secretion of inflammatory cytokines. XCR1− and XCR1+ cDC1 were sorted as shown in SI Appendix, Fig. S4. Subsequently, cells were stimulated or not either with 5 µg/mL R848 or 5 µg/mL pIC for 12 h. Supernatants of the cells were harvested and analyzed for the secretion of IL-12/IL-23p40, IL-12p70, IL-6, TNF, IFNλ1, IFNλ2/3, IFNα2, IFNβ, CXCL10, CCL3, CCL4, and CCL5 using the LEGENDplex Human Anti-Virus Response Panel (BioLegend). Samples were acquired using a BD LSRFortessa and data were analyzed using the LEGENDplex software suit (BioLegend). Scatter plots (black, filled circles: XCR1−; open circles: XCR1+) depict individual donors. Data for XCR1− and XCR1+ cDC1 from the same donor are connected by line. *P < 0.05; **P < 0.01 (N = 6, paired Student’s t test).CC BY-NC-ND · PubMed Central
Fig. 4. XCR1+ cDC1 excel in the activation of NK cells due to IL-12 secretion. Sorted XCR1− or XCR1+ cDC1 were cocultured with NK cells in a 1:5 ratio in presence or not of 2.5 µg/mL R848, 2.5 µg/mL pIC and 2.5 µg/mL CpG (Type A) as described in SI Appendix, Fig. S10A. After 18 h, supernatants were harvested and analyzed for the secretion of IFNγ by CBA Flex-Set (BD Biosciences) as well as NK cells for the expression of CD69 by flow cytometry. Samples were acquired using a BD LSRFortessa and analyzed using FlowJo (CD69 expression) or FCAP Array 3.1 (IFNγ secretion). (A) Scatter plots show ΔMFI for CD69 (N = 8, each donor connected by line) and secretion of IFNγ (N = 6, each donor connected by line). (B) Assay was performed as described in (A) with the addition of 10 µg/mL of a neutralizing anti-IL-12/IL-23p40 antibody (clone: C11.5) or an appropriate isotype control during the 18 h coculture. Scatter plots show ΔMFI for CD69 (N = 4, each donor connected by line) and secretion of IFNγ (N = 4, each donor connected by line). *P < 0.05; **P < 0.01 (paired Student’s t test).
Fig. 4. XCR1+ cDC1 excel in the activation of NK cells due to IL-12 secretion. Sorted XCR1− or XCR1+ cDC1 were cocultured with NK cells in a 1:5 ratio in presence or not of 2.5 µg/mL R848, 2.5 µg/mL pIC and 2.5 µg/mL CpG (Type A) as described in SI Appendix, Fig. S10A. After 18 h, supernatants were harvested and analyzed for the secretion of IFNγ by CBA Flex-Set (BD Biosciences) as well as NK cells for the expression of CD69 by flow cytometry. Samples were acquired using a BD LSRFortessa and analyzed using FlowJo (CD69 expression) or FCAP Array 3.1 (IFNγ secretion). (A) Scatter plots show ΔMFI for CD69 (N = 8, each donor connected by line) and secretion of IFNγ (N = 6, each donor connected by line). (B) Assay was performed as described in (A) with the addition of 10 µg/mL of a neutralizing anti-IL-12/IL-23p40 antibody (clone: C11.5) or an appropriate isotype control during the 18 h coculture. Scatter plots show ΔMFI for CD69 (N = 4, each donor connected by line) and secretion of IFNγ (N = 4, each donor connected by line). *P < 0.05; **P < 0.01 (paired Student’s t test).CC BY-NC-ND · PubMed Central
Fig. 5. XCR1+ cDC1 are superior in the induction of an antiviral state in epithelial cells. Sorted XCR1− and XCR1+ cDC1 were stimulated or not with 5 µg/mL pIC as described in SI Appendix, Fig. S10B Supernatants (SN) were harvested and used for the pretreatment of U2OS cells. After overnight culture, U2OS cells were challenged with luciferase-expressing Influenza virus type A (strain PR8-Luc). (A) Scatter plots show viral replication (% compared to nontreated infected cells) in U2OS cells after treatment with SN of XCR1− and XCR1+ cDCs ± stimulation with 5 µg/mL pIC. XCR1− (filled black circles: medium-treated; filled squares: pIC-treated) and XCR1+ cDC1 (open circles: medium-treated; open squares: pIC-treated) from the same donor are connected by lines (N = 12; **P < 0.01; paired Student’s t test). (B) SN from four donors were used for pretreatment of U2OS cells as in (A) and analyzed for the secretion of IFNλ1 by CBA assay (LEGENDplex Human Anti-Virus Response Panel). Scatter plots show inhibition of viral replication in U2OS cells correlated with the amount of IFNλ1 in the used SN for pretreatment (N = 4; XCR1− cDC1: black symbols, XCR1+ cDC1: white symbols; control-treated: circles, pIC-treated: squares, horizontal line depicts 50% inhibition of viral replication). Semilog line was fitted and Pearson Correlation Coefficient r and P value (two-tailed, exact) determined using GraphPad Prism9.
Fig. 5. XCR1+ cDC1 are superior in the induction of an antiviral state in epithelial cells. Sorted XCR1− and XCR1+ cDC1 were stimulated or not with 5 µg/mL pIC as described in SI Appendix, Fig. S10B Supernatants (SN) were harvested and used for the pretreatment of U2OS cells. After overnight culture, U2OS cells were challenged with luciferase-expressing Influenza virus type A (strain PR8-Luc). (A) Scatter plots show viral replication (% compared to nontreated infected cells) in U2OS cells after treatment with SN of XCR1− and XCR1+ cDCs ± stimulation with 5 µg/mL pIC. XCR1− (filled black circles: medium-treated; filled squares: pIC-treated) and XCR1+ cDC1 (open circles: medium-treated; open squares: pIC-treated) from the same donor are connected by lines (N = 12; **P < 0.01; paired Student’s t test). (B) SN from four donors were used for pretreatment of U2OS cells as in (A) and analyzed for the secretion of IFNλ1 by CBA assay (LEGENDplex Human Anti-Virus Response Panel). Scatter plots show inhibition of viral replication in U2OS cells correlated with the amount of IFNλ1 in the used SN for pretreatment (N = 4; XCR1− cDC1: black symbols, XCR1+ cDC1: white symbols; control-treated: circles, pIC-treated: squares, horizontal line depicts 50% inhibition of viral replication). Semilog line was fitted and Pearson Correlation Coefficient r and P value (two-tailed, exact) determined using GraphPad Prism9.CC BY-NC-ND · PubMed Central
Fig. 6. Differentiation of XCR1− cDC1 into XCR1+ cDC1 enables secretion of inflammatory cytokines. Sorted XCR1− and XCR1+ cDC1 were cultured in a DC differentiation assay as described in SI Appendix, Fig. S10C. On days 0, 4, and 6, cells were stimulated for 12 h or not with either 5 µg/mL pIC or R848. SN were harvested and cells were analyzed by flow cytometry for XCR1, BTLA, CD40, and CD86 expression. SN were analyzed for cytokine and chemokine secretion by CBA assay (LEGENDplex Human Anti-Virus Response Panel). (A) Scatter plots show XCR1 and BTLA expression (ΔMFI values), cell numbers as well as MFI value of CTV signal and (B) CD40 and CD86 expression (ΔMFI values) (filled black symbols: XCR1− cDC1; open symbols: XCR1+ cDC1; each individual donor has a distinct symbol and is connected by lines; N = 4; *P < 0.05, **P < 0.01; Two-way ANOVA). (C) Harvested SN of the samples in (B and C) were analyzed for the secretion of IFNλ1, IFNλ2/3, IL-6, TNFα, and IFNβ secretion by CBA assay (LEGENDplex Human Anti-Virus Response Panel). Concentration of the cytokines is shown as scatter plots (filled black circles: XCR1− cDC1; open circles: XCR1+ cDC1; individual donors connected by lines; N = 4; *P < 0.05, **P < 0.01; paired Student’s t test).
Fig. 6. Differentiation of XCR1− cDC1 into XCR1+ cDC1 enables secretion of inflammatory cytokines. Sorted XCR1− and XCR1+ cDC1 were cultured in a DC differentiation assay as described in SI Appendix, Fig. S10C. On days 0, 4, and 6, cells were stimulated for 12 h or not with either 5 µg/mL pIC or R848. SN were harvested and cells were analyzed by flow cytometry for XCR1, BTLA, CD40, and CD86 expression. SN were analyzed for cytokine and chemokine secretion by CBA assay (LEGENDplex Human Anti-Virus Response Panel). (A) Scatter plots show XCR1 and BTLA expression (ΔMFI values), cell numbers as well as MFI value of CTV signal and (B) CD40 and CD86 expression (ΔMFI values) (filled black symbols: XCR1− cDC1; open symbols: XCR1+ cDC1; each individual donor has a distinct symbol and is connected by lines; N = 4; *P < 0.05, **P < 0.01; Two-way ANOVA). (C) Harvested SN of the samples in (B and C) were analyzed for the secretion of IFNλ1, IFNλ2/3, IL-6, TNFα, and IFNβ secretion by CBA assay (LEGENDplex Human Anti-Virus Response Panel). Concentration of the cytokines is shown as scatter plots (filled black circles: XCR1− cDC1; open circles: XCR1+ cDC1; individual donors connected by lines; N = 4; *P < 0.05, **P < 0.01; paired Student’s t test).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Research works printed but not linked: 1

  1. L. Heger XCR1 expression distinguishes human conventional dendritic cells type 1 with full effector functions from their immediate precursors. Gene Expression Omnibus. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237715. Deposited 18 July 2023.

Cited by

See all 54

Metadata

Authors
Heger, L., Hatscher, L., Liang, C., Lehmann, C. H. K., Amon, L., Lühr, J. J., Kaszubowski, T., Nzirorera, R., Schaft, N., Dörrie, J., Irrgang, P., Tenbusch, M., Kunz, M., Socher, E., Autenrieth, S. E., Purbojo, A., Sirbu, H., Hartmann, A., Alexiou, C., Cesnjevar, R., & Dudziak, D.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Max Planck Institute for the Science of Light (DE)
  • German Cancer Research Center (DE)
  • Department of Thoracic Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91054 Erlangen, Germany
Corresponding author
  • Heger, Lukas
  • Dudziak, Diana
Venue
Proceedings of the National Academy of Sciences
Published
2023-08-11
Volume
120
Issue
33
Pages
e2300343120-e2300343120
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4385753890
Cited by
54
References
79
Citations by year
2026: 20 · 2025: 18 · 2024: 14 · 2023: 2
FWCI
5.92
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Deutsche Forschungsgemeinschaft (CRC1181-TPA7 DU548/5-1, GRK 2740 B02, SFB TR221/INF 324392634)
  • Agence Nationale de la Recherche (DU548/6-1)
  • Interdisziplinaeres Zentrum fuer klinische Forschung (IZKF-A80)
  • Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsfoerderung (DE-17-09-15-1-Heger)
  • Bavarian State of Ministry of Science and Art (Bayresq.net (IRIS))
  • Bundesministerium für Bildung und Forschung (Era-Net grant 01KT1801 CompLS program grant 031L0262C)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords
XCR1, XCL1, dendritic cell differentiation, dendritic cell precursors, NK cell activation, inflammatory cytokine secretion, chemokine secretion, influenza A virus, dendritic cell maturation, human dendritic cells
MeSH terms
Cell Differentiation, Dendritic Cells, Humans, Killer Cells, Natural, Cytokines, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors. https://app.cochat.ai/papers/10.1073/pnas.2300343120
The paper
Heger, L., Hatscher, L., Liang, C., Lehmann, C. H. K., Amon, L., Lühr, J. J., Kaszubowski, T., Nzirorera, R., Schaft, N., Dörrie, J., Irrgang, P., Tenbusch, M., Kunz, M., Socher, E., Autenrieth, S. E., Purbojo, A., Sirbu, H., Hartmann, A., Alexiou, C., . . . Dudziak, D. (2023). XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2300343120

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.